Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 13Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 5Prostatic Neoplasms 4Neoplasm Metastasis 3Melanoma 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Neoplastic Cells, Circulating 2Multiple Myeloma 2Lung Neoplasms 2Liver Neoplasms 2Glioblastoma 2Fibrosis 2Colorectal Neoplasms 2Cachexia 2Vascular Malformations 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Renal Insufficiency, Chronic 1Recurrence 1Pneumonia 1Ovarian Neoplasms 1Ovarian Cysts 1Osteosarcoma 1Obesity 1

Interventions

tocilizumab 1ceftolozane, tazobactam drug combination 1Observation 1Nebulizers and Vaporizers 1Lidocaine 1Immunoglobulin G 1Disulfides 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Pneumonia × Blood Specimen Collection × Clear all
NCT04040244 2023-10-11

Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis

Wake Forest University Health Sciences

Phase NA Terminated
16 enrolled 9 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Pneumonia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡